Clinical Trials on Idiopathic Pulmonary Fibrosis in United Kingdom
Total 5445 results
-
Theravance BiopharmaTerminatedIdiopathic Pulmonary Fibrosis (IPF)United Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
GlaxoSmithKlineCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
GlaxoSmithKlineTerminatedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Blade TherapeuticsWithdrawnIdiopathic Pulmonary FibrosisUnited Kingdom
-
GlaxoSmithKlineTerminatedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of NottinghamGlaxoSmithKline; McMaster University; Medical Research Council; CRAFT ConsortiumCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
GlaxoSmithKlineCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustGlaxoSmithKlineCompleted
-
Royal Brompton & Harefield NHS Foundation TrustKings Clinical Trials UnitCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Lung Therapeutics, IncCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Indalo Therapeutics, Inc.TerminatedIdiopathic Pulmonary Fibrosis | Healthy VolunteersUnited Kingdom
-
Imperial College LondonThe Leeds Teaching Hospitals NHS Trust; Norfolk and Norwich University Hospitals... and other collaboratorsCompletedIdiopathic Pulmonary Fibrosis | IPFUnited Kingdom
-
University Hospitals Coventry and Warwickshire...UnknownIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of East AngliaCompleted
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustActive, not recruiting
-
Manchester University NHS Foundation TrustRecruiting
-
Royal Brompton & Harefield NHS Foundation TrustUniversity of Nottingham; GlaxoSmithKline; University College, LondonCompletedIdiopathic Pulmonary Fibrosis | Idiopathic Non-specific Interstitial PneumonitisUnited Kingdom
-
University of North Carolina, Chapel HillRecruitingIdiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung DiseaseUnited States
-
Royal Brompton & Harefield NHS Foundation TrustCompleted
-
Norfolk and Norwich University Hospitals NHS Foundation...Norwich Clinical Trials UnitRecruitingIdiopathic Pulmonary FibrosisUnited Kingdom
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle UniversityCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Imperial College LondonCompletedChronic Obstructive Pulmonary Disease | Idiopathic Pulmonary FibrosisUnited Kingdom
-
Hull University Teaching Hospitals NHS TrustChiesi Farmaceutici S.p.A.CompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Galapagos NVCompletedIdiopathic Pulmonary FibrosisUnited Kingdom, Ukraine
-
University of California, San FranciscoCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
University of Colorado, DenverWithdrawn
-
Joshua M HareThe Emmes Company, LLC; The Lester And Sue Smith FoundationTerminatedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Johns Hopkins UniversityCelgene CorporationCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Wake Forest University Health SciencesMayo Clinic; The University of Texas Health Science Center at San AntonioCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Zambon SpACompletedPulmonary FibrosisSpain, Germany, Belgium, France, Italy, Netherlands, United Kingdom
-
University of Colorado, DenverRecruiting
-
BiogenCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Bristol-Myers SquibbCompletedHealthy Participants | Idiopathic Pulmonary Fibrosis (IPF)United States
-
Lung Therapeutics, IncRecruitingIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Germany
-
Andreas GuentherActive, not recruitingIdiopathic Pulmonary Fibrosis | Idiopathic Interstitial Pneumonia | Interstitial Lung Diseases | Diffuse Parenchymal Lung DiseasesUnited Kingdom, Germany, Austria, Italy, France
-
National Jewish HealthYale University; Icahn School of Medicine at Mount Sinai; AstraZeneca; Baylor University and other collaboratorsActive, not recruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, United Kingdom
-
InSilico Medicine Hong Kong LimitedRecruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
University of East AngliaInterMuneUnknownDepression | Anxiety | Idiopathic Pulmonary Fibrosis | DyspnoeaUnited Kingdom
-
University of DundeeBritish Lung Foundation; Newcastle University; University of Leicester; University... and other collaboratorsActive, not recruitingIdiopathic Pulmonary Fibrosis | Lung Diseases, Interstitial | Idiopathic Interstitial Pneumonias | Alveolitis, Extrinsic Allergic | Lung; Disease, Interstitial, With Fibrosis | Bird Fancier's LungUnited Kingdom
-
Galecto Biotech ABSyneos Health; bioRASI, LLCCompletedIdiopathic Pulmonary Fibrosis (IPF)United States, Spain, Israel, France, United Kingdom, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
-
Chiesi Farmaceutici S.p.A.Active, not recruitingIdiopathic Pulmonary FibrosisNorth Macedonia, Ukraine, United Kingdom
-
Galecto Biotech ABCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United Kingdom, Italy, Belgium, Germany, Netherlands, Finland, Denmark